AtaiBeckley (ATAI) Times Interest Earned (2022 - 2025)

AtaiBeckley (ATAI) recorded quarterly Times Interest Earned of -$22.63 in Q1 2025.

AtaiBeckley (ATAI) Times Interest Earned (2022 - 2025) Analysis & Trends

AtaiBeckley has disclosed Times Interest Earned across 4 years of filings, most recently posting -$95.73 for Q2 2025.

Times Interest Earned for Q2 2025 came in at -$95.73, down 161.2% year-over-year; the trailing twelve-month figure through Sep 2025 was -$49.31 (down 33.22% YoY), and the FY2024 annual result was -$32.87, up 30.42% from the prior year.
Times Interest Earned was -$22.63 for Q1 2025 at AtaiBeckley.
In the past five years, Times Interest Earned ranged from a high of -$22.63 in Q1 2025 to a low of -$95.73 in Q2 2025.
The 4-year median for Times Interest Earned is -$39.12 (2023), against an average of -$43.72.
Peak annual rise in Times Interest Earned reached 35.44% in 2025, while the deepest fall reached 161.2% in 2025.
AtaiBeckley's Times Interest Earned stood at -$40.7 in 2022, then fell by 19.34% to -$48.57 in 2023, then jumped by 34.54% to -$31.79 in 2024, then slumped by 201.13% to -$95.73 in 2025.
The last three Times Interest Earned figures came in at -$95.73 (Q2 2025), -$22.63 (Q1 2025), and -$31.79 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	AtaiBeckley	1.45 Bn	1.45 Bn	-	-

Download Data